Jyoti Malhotra Selected Research

Intramuscular Injections

1/2020

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jyoti Malhotra Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 04/2011
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 04/2016
10	Lung Neoplasms (Lung Cancer) 10/2023 - 12/2015
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2024 - 01/2021
3	Pneumonia (Pneumonitis) 05/2023 - 01/2020
2	Adenocarcinoma of Lung 10/2023 - 03/2022
2	Melanoma (Melanoma, Malignant) 07/2022 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 05/2021
2	Human Influenza (Influenza) 01/2022 - 01/2020
2	Diarrhea 05/2021 - 10/2019
2	Disease Progression 05/2021 - 01/2021
2	Infections 03/2021 - 01/2020
2	Inflammation (Inflammations) 03/2021 - 11/2019
2	Carcinogenesis 10/2016 - 03/2015
2	Breast Neoplasms (Breast Cancer) 12/2015 - 07/2014
1	Radiation Pneumonitis 05/2023
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 12/2022
1	Hemophilia A (Haemophilia) 12/2022
1	Clinical Deterioration 01/2022
1	COVID-19 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Testicular Neoplasms (Testicular Cancer) 11/2021
1	Anemia 05/2021
1	Dyspnea (Shortness of Breath) 05/2021
1	Neutropenia 05/2021
1	Hypophosphatemia 05/2021
1	Respiratory Insufficiency (Respiratory Failure) 05/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Headache (Headaches) 01/2021
1	Vomiting 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 06/2023 - 03/2015
4	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 09/2014
3	DystrophinIBA 01/2024 - 01/2021
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 01/2019
3	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 04/2016
3	RNA (Ribonucleic Acid)IBA 03/2021 - 10/2016
2	Riluzole FDA LinkGeneric 10/2023 - 07/2022
2	Immune Checkpoint InhibitorsIBA 05/2023 - 10/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 01/2022
2	pembrolizumabIBA 01/2020 - 04/2017
2	TIC10 compoundIBA 01/2019 - 08/2017
2	Bortezomib (Velcade)FDA Link 06/2014 - 04/2011
1	sotorasibIBA 03/2024
1	adagrasibIBA 03/2024
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	Tyrosine Kinase InhibitorsIBA 10/2023
1	Programmed Cell Death 1 ReceptorIBA 10/2023
1	NexusIBA 10/2023
1	Sorafenib (BAY 43-9006)FDA Link 10/2023
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	trametinibIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2022
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 12/2022
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 12/2022
1	talazoparibIBA 11/2022
1	ProdrugsIBA 07/2022
1	Glutamic Acid (Glutamate)FDA Link 07/2022
1	NivolumabIBA 07/2022
1	Fibrinogen (Factor I)FDA Link 03/2022
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2022
1	1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA 01/2022
1	montelukast (Singulair)FDA Link 01/2022
1	veliparibIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	PlatinumIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	CytokinesIBA 01/2022
1	Topoisomerase InhibitorsIBA 01/2022
1	AntigensIBA 11/2021
1	Protein Subunit VaccinesIBA 11/2021
1	Glycoproteins (Glycoprotein)IBA 05/2021
1	glembatumumab vedotinIBA 05/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	isochorismataseIBA 03/2021
1	Small Interfering RNA (siRNA)IBA 03/2021
1	navitoclaxIBA 01/2021
1	osimertinibIBA 01/2021
1	eteplirsenIBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021

Therapy/Procedure

18	Therapeutics 10/2023 - 01/2018
8	Immunotherapy 01/2023 - 04/2017
7	Drug Therapy (Chemotherapy) 10/2023 - 12/2012
7	Radiotherapy 05/2023 - 12/2012
3	Aftercare (After-Treatment) 10/2023 - 04/2011
2	Chemoradiotherapy 01/2020 - 04/2016
1	Length of Stay 01/2022